This inventor holds 4 USPTO granted patents and 11 published patent applications and 6 EPO patents. Top assignees: Genzyme Corporation, Sanofi, Sionna Therapeutics Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 825 
2 out of 1,546 
2 out of 2 Years Active: 2026
Title: Patrick Bernardelli - Innovator in Pharmaceutical Chemistry
Introduction: Patrick Bernardelli is a notable inventor based in Paris, France. He is currently employed at Sanofi, a global healthcare company focused on pharmaceuticals and vaccines. Although he has not yet been granted any patents, his work in the field of pharmaceutical chemistry is significant.
Latest Patent Applications: Patrick Bernardelli has submitted several innovative patent applications. One of his latest applications is titled "Novel Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Compounds and Their Derivatives, Processes for Their Preparation and Therapeutic Uses Thereof." This application discloses compounds that serve as inhibitors and degraders of estrogen receptors, with potential applications in treating various medical conditions such as ovulatory dysfunction, cancer, endometriosis, osteoporosis, benign prostatic hypertrophy, and inflammation. Another application is for "Substituted 6,7-Dihydro-5H-Benzo[7]Annulene Derivatives, Processes for Their Preparation and Therapeutic Uses Thereof," which similarly focuses on compounds with therapeutic potential in the same areas.
Conclusion: Patrick Bernardelli is an emerging inventor in the pharmaceutical industry, contributing to innovative solutions for significant health challenges. His ongoing research and patent applications reflect his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile